You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cardiac myosin activator

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Plasminogen Activator Inhibitor-1 Deficiency, Cardiac Fibrosis Trial (Metformin Extended Release Oral Tablet)

Not yet recruiting
  • Plasminogen Activator Inhibitor-1 Deficiency
  • Cardiac Fibrosis
  • Metformin Extended Release Oral Tablet
  • (no location specified)
Aug 1, 2022

Hypertrophic Cardiomyopathy Trial in United States (TN-201)

Not yet recruiting
  • Hypertrophic Cardiomyopathy
  • TN-201
  • Boston, Massachusetts
  • +6 more
Apr 18, 2023

Soluble Urokinase Plasminogen Activator Receptor in Non-cardiac

Completed
  • Surgery--Complications
  • Soluble Urokinase Plasminogen Activator Receptor
  • Larisa, Thessaly, Greece
    University Hospital of Larisa, Department of Anesthesiology
Nov 11, 2020

Heart Failure Trial in Orlando (AMG 423)

Completed
  • Heart Failure
  • AMG 423
  • Orlando, Florida
    Research Site
Jul 25, 2021

Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

Not yet recruiting
  • Pericarditis
  • IL1RA Antibody Assay
  • suPAR Testing
  • Homburg, Germany
  • +8 more
Jun 22, 2023

Myocardial Infarction, Acute Trial in Cairo (No intervention)

Completed
  • Myocardial Infarction, Acute
  • No intervention
  • Cairo, Egypt
    Biochemistry Department, Faculty of Pharmacy and Biotechnology,
Jan 18, 2023

CHF Trial in Dallas (Istaroxime, Exercise)

Completed
  • Heart Failure, Congestive
  • Dallas, Texas
    The Institute for Exercise and Environmental Medicine
Jun 22, 2022

Hypertrophic Cardiomyopathy Trial in Shanghai (Mavacamten)

Completed
  • Hypertrophic Cardiomyopathy
  • Shanghai, Shanghai, China
    Huashan Hospital Fudan University
Jul 28, 2022

Obstructive Hypertrophic Cardiomyopathy Trial in Beijing (Mavacamten, Placebo)

Recruiting
  • Obstructive Hypertrophic Cardiomyopathy
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jan 17, 2022

Modified Release Oral Formulation, Left Ventricular Systolic Dysfunction, Chronic Heart Failure Trial in Worldwide (Omecamtiv

Completed
Has Results
  • Modified Release Oral Formulation
  • +6 more
  • Omecamtiv Mecarbil Matrix F1 Formulation
  • +3 more
  • Mobile, Alabama
  • +100 more
Jul 25, 2021

Cyanotic Congenital Heart Disease, Pediatric HD Trial in Adana (Propofol, Sevoflurane)

Completed
  • Cyanotic Congenital Heart Disease
  • Pediatric HD
  • Adana, Turkey
    Cukurova University
Mar 30, 2022

Surgery-Complications Trial in Montreal (Crystalloid fluid infusion)

Recruiting
  • Surgery-Complications
  • Crystalloid fluid infusion
  • Montreal, Quebec, Canada
    Centre Hospitalier de l'Université de Montréal (CHUM)
Apr 17, 2023

Class II Growth Modification Trial in Cairo (Van-Beek activator and a headgear, Andresen activator)

Enrolling by invitation
  • Class II Growth Modification
  • Van-Beek activator and a headgear
  • Andresen activator
  • Cairo, القاهرة, Egypt
    Alazhar University
Oct 30, 2022

Ocular Trauma Trial in Hangzhou (Tissue Plasminogen Activator)

Recruiting
  • Ocular Trauma
  • Tissue Plasminogen Activator
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Feb 20, 2023

Muscular Dystrophies Trial in Lincoln (EDG-5506)

Enrolling by invitation
  • Muscular Dystrophies
  • Lincoln, Nebraska
    Celerion, Inc.
Aug 5, 2022

Breast Cancer, Metastatic Breast Cancer, Cancer Therapy-Related Cardiac Dysfunction Trial in Lørenskog (Nicotinamide Riboside,

Not yet recruiting
  • Breast Cancer
  • +4 more
  • Nicotinamide Riboside
  • Placebo
  • Lørenskog, Akershus, Norway
    Akershus University Hospital
Feb 14, 2023

Immune Aging, Aging Trial in Frankfurt (Softgel containing , Softgel containing 250mg of Urolithin A (Mitopure))

Recruiting
  • Immune Aging
  • Aging
  • Softgel containing placebo
  • Softgel containing 250mg of Urolithin A (Mitopure)
  • Frankfurt, Germany
    Universitätsklinikum Frankfurt, Medizinische Klinik I, Gastroent
Feb 9, 2023

Diaphragm Issues Trial (Stimit Activator 1)

Not yet recruiting
  • Diaphragm Issues
  • Stimit Activator 1
  • (no location specified)
May 20, 2023

Health Subjects Trial (A4368 or tablet)

Completed
  • Health Subjects
  • A4368 or placebo tablet
  • Seoul, Korea, Republic of
    AutophagySciences
Jan 16, 2023

Solid Tumor Trial in Shanghai (LB4330)

Recruiting
  • Solid Tumor
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jan 31, 2023

Acute Ischemic Stroke Trial in China (rt-PA, rhTNK-tPA)

Completed
  • Acute Ischemic Stroke
  • Hefei, Anhui, China
  • +60 more
Jan 13, 2023

Peri-Implantitis Trial in Van (Er, Cr: YSGG laser-assisted non-surgical mechanical therapy, Non-surgical mechanical therapy)

Completed
  • Peri-Implantitis
  • Er, Cr: YSGG laser-assisted non-surgical mechanical therapy
  • Non-surgical mechanical therapy
  • Van, Turkey
    Nazli Zeynep Alpaslan
Sep 13, 2023

Antifibrinolytic Agents Trial in Berne (Tranexamic acid bolus 20 mg/kg, Tranexamic acid bolus 10 mg/kg, Tranexamic acid bolus 1

Not yet recruiting
  • Antifibrinolytic Agents
  • Tranexamic acid bolus 20 mg/kg
  • +3 more
  • Berne, Switzerland
    Dpt. Anesthesiology and pain Medicine
Nov 13, 2023

Acute Stroke Trial in Izmir (theory training, theory and simulation training)

Completed
  • Acute Stroke
  • theory training
  • theory and simulation training
  • İzmir, Turkey
    Ozge Soydaner
Jul 15, 2022

Obesity Trial in Scottsdale (Exercise, Infusion of Amino Acids)

Recruiting
  • Obesity
  • Exercise
  • Infusion of Amino Acids
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jun 6, 2022